Werner Verbiest

Global Head, Janssen Diagnostics

Luc Truyen, MD, PhD.

Global Head of Development & External Affairs, Neuroscience Therapeutic Area – Janssen R&D, LLC

J.D. Alvarez, M.D., Ph.D.

Vice President, Oncology Diagnostics, for the Janssen Pharmaceutical Companies of Johnson & Johnson

Mariano Alvarez, PhD

Chief Scientific Officer, DarwinHealth™

Ashish Atreja, MD, MPH

Asst. Professor & Chief Innovation Officer, Icahn School of Medicine at Mount Sinai

Dina Avery, DHSc, MA, MAEd

Assistant Professor & Regulatory Affairs Specialist, University of Alabama at Birmingham

John M. Baldoni, PhD

Senior Vice President, In silico Drug Discovery, GSK Pharma R&D

Annette Bakker, Ph.D.

President and Chief Scientific Officer, the Children’s Tumor Foundation

Michele M. Becci, MBA

Vice President, Industry Strategy at Medidata Solutions

Christina Bender, PhD, MBA

Director, Global Diagnostic Pipeline Strategy – Novartis

Carol Berry, MBA

Senior Vice-President and Chief Business Officer, Caprion Biosciences Inc.

Wayne Caldwell

Director – Diaceutics Inc.

Jim Cassidy MD PhD

Corporate VP, Celgene

Gregory J. Downing, D.O., Ph.D.

Founder of Innovation Horizons, LLC

Ysabel Duron

Founder & Director, Latino Cancer Institute

Jim Fackler, M.D.

Associate Professor, Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine

Andrea Ferris

President & CEO, LUNGevity Foundation

Ryan Fukushima, MBA

Chief Operating Officer, Tempus

Anita Krithivas Gandhi, Ph.D

Senior Director, Translational Development and Diagnostics Department, Celgene Corporation

Marc Grodman, MD

Co-Founder & CEO, Genosity

Sarah Hersey, MS, MBA, RAC

Head of Precision Medicine and Companion Diagnostics, Celgene Corporation

Jeffrey R. Idle, PhD

Endowed Professor and Director, Arthur G. Zupko’s Systems Pharmacology and Pharmacogenomics, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University

Jay S Kaufman, Ph.D.

Professor, Department of Epidemiology, Biostatistics and Occupational Health, McGill University

Kevin Kalinsky, M.D., M.S

Assistant Professor of Medicine at the NewYork-Presbyterian Hospital/Columbia University Medical Center

Peter Kapitein, PhD

Founder Inspire2Live

Mark G. Kris, MD

Attending Physician, Thoracic Oncology Service, The William and Joy Ruane Chair in Thoracic Oncology, Lead Physician, Memorial Sloan Kettering–IBM Watson Collaboration

Eric B. Kmiec, Ph.D

Founder and Director of the Gene Editing Institute at the Helen F. Graham Cancer Center & Research Institute at Christiana Care Health System

Michael Kolodziej M.D.

Vice President and Chief Innovation Officer, ADVI Health

Andrew Kung, MD, PhD

Pediatric Oncologist, Chair, Department of Pediatrics, MSKCC

Arturo Loaiza-Bonilla, MD MSEd FACP

Chief of Medical Oncology and Medical Director of Research at Cancer Treatment Centers of America – ERMC, and also Co-Founder and Chief Medical Officer at Massive Bio

J Blake Long, MD, MBA

President, Long Health Care Consulting

Hannah Mamuszka

Founder and CEO of Alva10

Jennifer Manly, PhD

Associate Professor of Neuropsychology in Neurology at the Taub Institute for Research in Alzheimer’s Disease and the Aging Brain at Columbia University

Maurie Markman, MD

President of Medicine & Science at Cancer Treatment Centers of America.

Anne-Marie Martin Ph.D.

Senior Vice President and Global Head of Precision Medicine, Novartis

Glenn A. Miller, Ph.D.

Partners Healthcare Innovation’s Market Sector Leader for Radiology, Anesthesiology, Neurology, Neurosurgery and Psychiatry

Robert S. Miller, MD, FACP, FASCO

Vice President and Medical Director, CancerLinQ®

Spyro Mousses, PhD

Executive Scientific Advisor, Medical Intelligence and Innovation Institute Children’s Hospital of Orange County, CEO Systems Oncology